2011
DOI: 10.2147/ijwh.s23814
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial treatment of bacterial vaginosis: current and emerging therapies

Abstract: Bacterial vaginosis is a common cause of malodorous vaginal discharge. It is also associated with sexually transmitted infections and adverse pregnancy outcomes. The magnitude of the gynecological and obstetrical consequences has stimulated therapeutic research and led to the testing of several therapies. The objective of this work is to present the currently available therapeutic strategies for the treatment of bacterial vaginosis and associated recommendations, and discuss the emerging therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
74
0
10

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(85 citation statements)
references
References 88 publications
1
74
0
10
Order By: Relevance
“…Tinidazole, an antimicrobial agent initially used for Trichomonas vaginalis infections has also been shown to be effective for bacteria vaginosis. Available data suggest that tinidazole has a role in special populations particularly for refractory or relapsing bacteria vaginosis [16,17]. In our study, cefpodoxime, cefixime and ciprofloxacin were also used in remarkable number of cases of infectious vaginitis.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…Tinidazole, an antimicrobial agent initially used for Trichomonas vaginalis infections has also been shown to be effective for bacteria vaginosis. Available data suggest that tinidazole has a role in special populations particularly for refractory or relapsing bacteria vaginosis [16,17]. In our study, cefpodoxime, cefixime and ciprofloxacin were also used in remarkable number of cases of infectious vaginitis.…”
Section: Discussionmentioning
confidence: 73%
“…Metronidazole is used to treat bacterial as well as trichomoniasis infection of the vagina [4]. Until now Metronidazole and clindamycin are regarded as the mainstay of therapy in the treatment of bacterial vaginosis [16]. Recently tinidazole is also used as an alternative.…”
Section: Discussionmentioning
confidence: 99%
“…In a multicenter randomized control trial of 112 women with recurrent BV, suppressive therapy with twice weekly 0.75% metronidazole gel for 6 months after initial treatment achieved a significant reduction in symptomatic recurrence compared with placebo. 13 A recent meta-analysis demonstrated that hormonal contraceptive use may also be protective against BV. 11 Data on probiotics containing Lactobacillus show mixed results, with insufficient evidence for or against recommending probiotics for the treatment of BV.…”
Section: Recurrencementioning
confidence: 99%
“…Both harbor good efficacy against protozoal and anaerobic infection (1,2). Drugs are available in oral, vaginal, topical, intravenous preparation (5).…”
Section: Introductionmentioning
confidence: 99%